Search for more news
Custom Search
Pharmaceutical market did not go down in January, either
Posted on March 21st, 2010
Pharmaceutical market did not go down in January, either
The Romanian pharmaceutical market rose by 12% in RON in January against January 2009, to 748.54m RON (180.76m euros), according to Cegedim Romanian data. The market is thus following the same upward trend of recent years, which saw it go up by 13.1% in 2009 year-on-year and by 17.7% in 2008.
Read more:
Pharmaceutical market did not go down in January, either
All the news from Romania published by Ziarul Financiar
Similar news from Romania:
- Pharma giants generate 1.5bn-euro sales
- Expensive drugs push pharmaceutical market up by 17% in RON in Q1
- Expensive drugs push pharmaceutical market up by 17% in RON in Q1
- Aspirin, the oldest brand in drug industry, still generates sales of millions of euros
- Romania Sees Crime Rate Up 13% In ’09 – Interior Ministry
- Energy players: Stagnation is the best-case scenario this year
- Angelli: Real growth opportunities reside in exports
- Romanians start to prefer RON over foreign currency for deposits
- Cancer drugs drive Roche sales up 20%
- The economic downturn sent the telecom market back three years
- Antidepressant market likely to rebound as a result of recession
- Drugstores close to hospitals derive highest revenues
- M&A market reaches H1 2009 level in two months
- Stoica: This will be the year of those who save themselves
- Romania 1H Overdue Private Loans +67% On Year At RON13.6B
- Romania’s Jan-Jul Public Debt Rises To 27.9% Of GDP
- Drugstores make over 25m euros from baby food, but lost battle for new clients
- No change of leaders among top 50 best-selling drugs on Romanian market
- FDIs expected to amount to €5 bln in 2009, half the 2008 level
- Roche makes more than 100m euros from three drugs
- Anti-stress product market goes up by 16% during crisis
- A&D Pharma reports 33% growth, credits restructuring
- Romania's current account deficit dropped 73.2% in January. Sums sent by overseas Romanians went up
- A&D Pharma sees 7% growth in Q3, to over 131m euros
- Wine market grows in volume, but drops in value
RSS
News Archive
News Calendar
News by Sources
Friends